Current Research Activities
Research translates into patient access to the highest quality and latest advancements in medicine today. Programs in research enable our hospitals to bring new medical advances to the bedside – and to medical professionals and patients worldwide.
Brigham and Women's Hospital and Massachusetts General Hospital continue to top the list of independent hospital recipients of National Institutes of Health (NIH) funding in the country. McLean Hospital ranks as a top recipient among private psychiatric hospitals.
Partners researchers are at the forefront of ongoing research activities in drug discovery, genetics, clinical patient care, diagnostics, information technology and preventive medicine.
As an integrated health care system, when we make a medical discovery at any one of our hospitals, patients at all of our hospitals and health centers benefit.
We invite you to learn more about current and ongoing medical research at Partners affiliates.
Basic and clinical research is fundamental to the mission of Partners HealthCare. The research enterprise, which covers the spectrum from basic science to translational and clinical investigation, accounts for nearly $1.2 billion of research revenue.
The Translational Medicine Center is pioneering an innovative partnership between academia and industry to create new models of drug development for effectively combating human diseases. New therapeutics require a new paradigm.
The Partners HealthCare Center for Personalized Genetic Medicine promotes genetics and genomics research and helps realize the promise of personalized medicine by accelerating the integration of genetic knowledge into clinical care.
Partners Pharmacovigilance includes a spectrum of services to detect, explore, validate, and prospectively monitor adverse events associated with drug therapies.
The Biorepository for Medical Discovery collects and maintains samples and information from individuals treated at Massachusetts General Hospital and Brigham and Women’s Hospital which are used in research to better understand, prevent, and treat many different diseases. A large collection of specimens associated with medical information from participants is the foundation of research necessary to personalize medical treatment in the future.
A nonprofit consortium of Boston teaching hospitals and engineering schools, the Center for Integration of Medicine & Innovative Technology fosters collaboration among world-class experts in medicine, science and engineering, in concert with industry and government, to improve patient care.
Partners Biomedical Engineering ensures that technology is used appropriately and safely, performs properly and is managed cost-effectively.
This network offers a rich environment for training the next generation of heart failure clinical investigators. Trainees acquire the skills necessary to perform clinical and translational heart failure research as a lifelong endeavor.
Clinical Trials & Studies
Partners Research Study Volunteer Program (RSVP) is recruiting for dozens of current and future studies.
Partners' Strategic Initiative: A Case for Change
Partners' President and CEO, Gary Gottlieb, MD, outlines Partners' vision for the future.
Innovation and Leadership
Partners leadership is dedicated to developing new and improved methods of care delivery, treatments, and cutting-edge research.